Drug Database · Clinicians

Chlorphenamine + Dextromethorphan + Guaifenesin + Phenylpropanolamine

Also known as: chlorpheniramine (US name, for chlorphenamine) · guaiphenesin (former British name, for guaifenesin)

Brands (2) Mucobron Forte, PlemeridShow all

Expectorant/Antitussive/Nasal Decongestant/Antihistamine; Expectorants/Cough Suppressants/Decongestants/ antihistamines PH FDA category
Fixed-dose combination.

Controlled precursorRx · Prescription drug2 PH products

1988 Convention Table I (norephedrine); FDA-registered oral preparations are exempt from all DDB regulatory requirements except registration and licensing of the importer, exporter and manufacturer; prescription and dispensing follow FDA rules (BR 1 s.2014 Sec. 4(5)). Parenteral preparations are not covered by this exemption (Sec. 4(2)(c)(i)); prescribing a drug preparation containing a controlled chemical otherwise requires a PDEA S-2 license (Sec. 6(3)).; BR 1 s.2014 Sec. 6(14)-(15): preparations with norephedrine/phenylpropanolamine 25 mg or below that are classified over-the-counter may be advertised to the public and distributed as samples; the S-2 license fee schedule (Sec. 6) likewise excludes them. The precursor exemption for oral FDA-registered preparations applies to combinations as well (BR 1 s.2014 Sec. 4(5)). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions).

Dispensing: Prescription (Rx) · Controlled precursor Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat US FDA label

  • Use: Uses temporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the impulse to cough to help you get to sleep US FDA label

  • Use: Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Capsule: 50 mg/10 mg/25 mg/2 mg
  • Syrup: 50 mg/10 mg/10 mg/2 mg per 5 mL

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Chlorphenamine + Dextromethorphan + Guaifenesin + Phenylpropanolamine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Chlorphenamine + Dextromethorphan + Guaifenesin + Phenylpropanolamine
Package insert
Mucobron ForteGuaifenesin + Dextromethorphan Hydrobromide + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
50 mg/10 mg/25 mg/2 mg CapsuleStrip Foil x 10's (Box of 100's)
Rx
Medi-Rx, Inc.Philippines
—
DR-XY33008
Feb 21, 2027
PlemeridGuaifenesin + Dextromethorphan Hydrobromide + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
50 mg / 10 mg / 10 mg/ 2 mg per 5 mL SyrupAmber bottle x 60mL (Box of 1's)
Rx
Hizon Laboratories, Inc.Philippines
Trader: Healthlink 211 Pharma, Inc.
DRP-8803
Jan 21, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .